Metformin & Prostate Cancer [a84137]

Maintaining Optimal Health: Understanding Blood Sugar Levels After Eating

The body's ability to regulate blood sugar levels is crucial for overall health. A balanced range of 70-99 mg/dL after eating indicates proper insulin function and glucose metabolism.

Blood sugar fluctuations can occur due to various factors, including diet, exercise, stress, and sleep quality. Dietary Habits: Balancing Blood Sugar explains blood sugar levels 2 hours after eating how consuming foods with a high glycemic index (GI) can cause blood sugar spikes. Foods like white bread, pasta, and sugary snacks rapidly increase blood glucose levels.

Insulin Sensitivity: The Key to Glucose Regulation

Insulin resistance is a common issue that affects up to 1 in 4 adults worldwide. It occurs when the body becomes less responsive to insulin, leading to elevated blood sugar levels. Physical Activity's Impact on Blood Sugar Levels highlights how regular exercise low blood sugar and adhd can improve insulin sensitivity and reduce glucose fluctuations.

Stress plays a significant role in affecting blood sugar ranges. The emotional response triggers an increase in cortisol production, which impairs glucose regulation. Consuming healthy fats like nuts and avocados helps stabilize blood sugar levels during periods of stress.

Monitoring blood sugar regularly is essential for maintaining optimal health. Using tools such as glucometers or continuous glucose monitoring (CGM) systems can help track fluctuations throughout the day.

Balancing Blood how to keep blood sugar stable overnight Sugar: A Holistic Approach

Combining diet, exercise, and stress management techniques helps achieve a balanced blood sugar range. Regular sleep patterns also contribute to healthy glucose regulation.

PCRI’s Executive Director, Mark Scholz, MD, discusses the off-label use of Metformin as a treatment for prostate cancer. He describes the limitations of studies conducted up to this point, explains the logic of Metformin’s anti-cancer potential, and describes situations in which it is wise to consider using Metformin as part of a treatment plan. :09 Metformin is a medicine typically used to treat people with diabetes by lowering their blood sugar. It is mild and relatively safe for people without diabetes since it does not usually cause a significant decline in blood sugar. Retrospective studies have shown that men who had both prostate cancer and diabetes simultaneously lived longer (as it concerned their prostate cancer) if they took Metformin compared to men who did not take Metformin. 1:16 The reason why Metformin would have an anti-cancer effect is that it lowers insulin, a growth hormone that stimulates the growth of prostate cancer cells. There are not, however, any prospective studies that test the use of Metformin as an isolated treatment on large groups of men without diabetes. 2:14 Despite the lack of conclusive empirical studies, men with prostate cancer (especially men with more aggressive forms of prostate cancer) might want to consider talking to their doctor about using Metformin in conjunction with their other treatments since it is mild, inexpensive, and there are strong logical reasons to believe it improve outcomes. Don’t know your stage? Take the quiz: Visit To learn more about prostate cancer visit To download the free Staging Guide visit Who we are: The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any question that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors. The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs. #ProstateCancer #Prostate #MarkScholzMD